Treatment-refractory Acute Graft-versus-Host Disease
1 clinical trials · Condition
◉ Watch Treatment-refractory Acute Graft-versus-Host Disease
| Record | Firm | Date |
|---|---|---|
| Neihulizumab (ALTB-168) in Patients With Steroid-refractory Acute Graft-versus-host Disease or Treatment-refractory Acute Graft-versus-host Disease (NCT03327857) | AltruBio Inc. | 2018-05-31 |
Track Treatment-refractory Acute Graft-versus-Host Disease automatically
Every clearance here is in the API, with alerts when new ones post.